Citation Impact

Citing Papers

New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
2010
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Peripheral Blood Progenitor Cell Transplantation: Clinical, Practical, and Economic Considerations
1994
Addition of a Low Fixed Number of CD3 + Cells to CD34-Enriched Allografts: Effects on Engraftment, Graft-versus-Host Disease, and Survival after Related and Unrelated Peripheral Stem Cell Transplantation
2003
Challenges in the Treatment of Chronic Wounds
2015 Standout
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Apoptosis. Its significance in cancer and cancer Therapy
1994 Standout
TNF promotes metastasis by impairing natural killer cell activity
1996
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989
Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2′-deoxycoformycin
1992
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Neutrophils at work
2014 Standout
Advances in stem cell mobilization
2012
Development in the thymus: it takes two to tango
1993 Standout
Primed marrow for autologous and allogeneic transplantation: A review comparing primed marrow to mobilized blood and steady-state marrow
2004
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy?
1989
Bone marrow autotransplantation
1989
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
2006 Standout
Functional and physical communication between oncoproteins and tumor suppressors
2005
Mobilization and collection of peripheral blood progenitor cells for transplantation
2005
The effect of the JE (MCP‐1) gene, which encodes monocyte chemoattractant protein‐1, on the growth of hela cells and derived somatic‐cell hybrids in nude mice
1995 StandoutNobel
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Chemotherapy and the war on cancer
2005 Standout
Bone marrow‐derived stem cells in wound healing: a review
2007
Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical Sibling
1989 Standout
Graft-versus-host disease
2009 Standout
Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells
1990
Treatment of hairy-cell leukemia
1990
Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma.
1994
Lung-restricted Activation of the Alveolar Macrophage/Monocyte System in Pulmonary Sarcoidosis
1992
Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells
1996
GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN
1988
Reflecting on 25 years with MYC
2008 Standout
Quality evaluation of umbilical cord blood progenitor cells cryopreserved with a small-scale automated liquid nitrogen system
2008 StandoutNobel
Sarcoidosis
1997 Standout
Bone Marrow Transplantation
1994
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Microenvironmental regulation of metastasis
2008 Standout
Quality of Umbilical Cord Blood CD34 + Cells in a Double-Compartment Freezing Bag Cryopreserved without a Rate-Controlled Programmed Freezer
2007 StandoutNobel
Natural compounds for cancer treatment and prevention
2009 Standout
Idarubicin
1991
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining
2005
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
2004
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
1999 Standout
The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man
2008
Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor.
1992
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
1999 Standout
Matrix metalloproteinases and tumor metastasis
2006 Standout
Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure
1994
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Effects ofBCR-ABLAntisense Oligonucleotides (AS-ODN) on Human Chronic Myeloid Leukemic Cells: AS-ODN as Effective Purging Agents
1995
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
2005
Cancer of the Ovary
2004 Standout
TIMP-1 Alters Susceptibility to Carcinogenesis
2004
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.
1989
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
2010 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells
1998
The rate of telomere sequence loss in human leukocytes varies with age
1998 StandoutNobel
The cytokine wall chart
1993
Evolution of the immune system in humans from infancy to old age
2015 Standout
Leukocyte-endothelial adhesion molecules
1994 Standout
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
1997
Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients
1988
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation
2000 StandoutNobel
Peripheral Blood Stem Cell Transplantations: Past, present and future
1993
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
The pharmaceutics and delivery of therapeutic polypeptides and proteins
1993
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Bone Marrow Transplant
1990 Standout
Human Adipose Tissue Is a Source of Multipotent Stem Cells
2002 Standout
Factors Affecting Wound Healing
2010 Standout
Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes.
1990
Growth Factors and Cancer
1991 StandoutScience
The cytokine network
1989
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
1995
Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma
2002
Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?
2007
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Evaluation of Hematological Reconstitution Potential of Autologous Peripheral Blood Progenitor Cells Cryopreserved by a Simple Controlled-Rate Freezing Method
2004 StandoutNobel
Multiple Myeloma
2011 Standout
Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
1991
Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factor
1990
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor
1998

Works of AD Ho being referenced

Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation
2001
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation
2002
Autologous and allogeneic stem cell transplantation in multiple myeloma
2000
Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine
2002
Centrosome replication, genomic instability and cancer
2002
Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor
1988
Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor [letter; comment]
1990
Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma
1990
Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo
1988
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma
2006
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia
1989
Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma
1986
Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes
1994
Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor
1988
Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma
1986
Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor [letter; comment]
1990
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia
1990
Rankless by CCL
2026